Tag : AGE-RELATED MACULAR DEGENERATION

CONFERENCE UPDATE

Psoriasis associated with increased risk of AMD: Evidence from a retrospective observational cohort study
A retrospective cohort study found that psoriasis patients aged 55 and older had a higher risk of age-related macular degeneration (AMD) compared to matched controls, suggesting the need for vigilant screening for ocular comorbidities in psoriasis management and the potential impact of lipid dysregulation on AMD progression.
NEWS AND PERSPECTIVE

Photoactivatable nanosystem combining PDT and VEGF inhibition: A potentially safe and effective intravenous wAMD therapy
Current treatments for wet age-related macular degeneration (wAMD) include the use of vascular endothelial growth factor (VEGF) inhibitors and the use of photodynamic therapy (PDT). Combination of these therapies may offer significant improvements in visual acuity but safety concerns remain. Researchers from the University of Hong Kong Faculty of Medicine (HKUMed) reported the development of a novel and minimally invasive approach to wAMD treatment, by intravenously administering a photoactivatable nanosystem and irradiating the diseased eyes.